Interleukin-8 and Other Agonists of Gi2 Proteins: Autocrine Paracrine Growth Factors for Human Hematopoietic Progenitors Acting in Synergy with Colony Stimulating Factors

References

• Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annual Reviews in Immunology 1997; 15: 675–705
   PubMed Web of Science ®Google Scholar
• Broxmeyer H. E., Kim C. H. Regulation of hemat-opoiesis in a sea of chemokine family members with a plethora of redundant activities. Experimental Hematology 1999; 27: 1113–1123
   PubMed Web of Science ®Google Scholar
• Shadendorf D., Moller A., Algermissen B., Worm M., Sticherling M., Czarnetzki B. M. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. Journal of Immunology 1993; 151: 2667–2675
   PubMed Web of Science ®Google Scholar
• O'Garra A., McEvoy L. M., Zlotnik A. T-cell subsets: Chemokine receptors guide the way. Current Biology 1998; 8: R646–R649
   PubMed Web of Science ®Google Scholar
• Laterveer L., Lindley I. J. D., Hamilton M. S., Willemze R., Fibbe W. E. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long term myelolymphoid repopulating ability. Blood 1995; 85: 2269–2275
   PubMed Web of Science ®Google Scholar
• Behringer D., Kresin V., Henschler R., Mertelsmann R., Lindemann A. Cytokine and chemokine production by CD34+ haemopoietic progenitor cells: detection in single cells. British Journal of Haemarology 1997; 91: 9–14
   Web of Science ®Google Scholar
• Corre I., Pineau D., Hermouet S. Interleukin-8: an autocrine/ paracrine growth factor for human hematopoietic progenitors acting in synergy with Colony Stimulating Factor-1 to promote monocyte-macrophage growth and differentiation. Experimental Hematology 1999; 27: 28–36
   PubMed Web of Science ®Google Scholar
• Cluitmans F. H. M., Esendam B. H. J., Landegent J. E., Willemze R., Falkenburg J. H. F. Constitutive in vivo cytokine and hematopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals. Blood 1995; 85: 2038–2044
   PubMed Web of Science ®Google Scholar
• Kaplanski G., Farnarier C., Kaplanski S., Porat R., Shapiro L., Bongrand P., Dinarello C. A. Inter-leukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism. Blood 1994; 84: 4242–4248
   PubMed Web of Science ®Google Scholar
• Jeannin P., Delneste Y., Gosset P., Molet S., Lassalle P., Hamid Q., Tsicopoulos A., Tonnel A. B. Hista-mine induces interleukin-8 secretion by endothelial cells. Blood 1994; 84: 2229–2233
   PubMed Web of Science ®Google Scholar
• Hashimoto S., Yoda M., Yamada M., Yanai N., Kawashima T., Motoyoshi K. Macrophage colony-stimulating factor induces interleukin-8 production in human monocytes. Experimental Hematology 1996; 24: 123–128
   PubMed Web of Science ®Google Scholar
• Denizot Y., Godard A., Raher S., Trimoreau F., Praloran V. Lipid mediators modulate the synthesis of interleukin-8 by human bone marrow stromal cells. Cytokine 1999; 11: 606–610
   PubMed Web of Science ®Google Scholar
• Aman M. J., Rudolf G., Goldschmitt J., Aulitzky W. E., Lam C., Huber C., Peschel C. Type-l interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells. Blood 1993; 82: 2371–2378
   PubMed Web of Science ®Google Scholar
• Roebuck K. A. Regulation of interleukin-8 expression. Journal of Interferon and Cytokine Research 1999; 19: 429–438
   PubMed Web of Science ®Google Scholar
• Eliopolous A. G., Gallagher N. J., Blake S. M., Dawson C. W., Young L. S. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein-1 coregulates inter-leukin-6 and interleukin-8 production. Journal of Biological Chemistry 1999; 274: 16085–16096
   PubMed Web of Science ®Google Scholar
• Jones S. A., Dewald B., Clark-Lewis I., Baggioloni M. Chemokine antagonists that discriminate between interleukin-8 receptors. Journal of Biological Chemistry 1997; 272: 16166–16169
   PubMed Web of Science ®Google Scholar
• Denizot Y., Fixe P., Liozon E., Praloran V. Serum interleukin-8 (IL-8) and IL-6 concentrations in patients with hematologic malignancies. Blood 1996; 87: 4016–4017
   PubMed Web of Science ®Google Scholar
• Tobler A., Moser B., Dewald B., Geiser T., Studer H., Baggiolini M., Frey M. Constitutive expression of interleukin-8 and its receptor in human myeloid and lym-phoid leukemia. Blood 1993; 82: 2517–2525
   PubMed Web of Science ®Google Scholar
• Vinante F., Rigo A., Vincenzi C., Ricetti M. M., Marro-chella R., Chilosi M., Cassatella M. A., Bonazzi L., Pizzolo G. IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells. Leukemia 1993; 7: 1552–1556
   PubMed Web of Science ®Google Scholar
• di Celle P. F., Carbone A., Marchis D., Zhou D., Sozzani S., Zupo S., Pini M., Mantovani A., Foa R. Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein. Blood 1994; 84: 220–228
   PubMed Web of Science ®Google Scholar
• Murphy P. M. The molecular biology of leukocyte chemoattractant receptors. Annual Reviews in Immunology 1994; 12: 593–633
   PubMed Web of Science ®Google Scholar
• Arvanitakis L., Geras-Raaka E., Varma A., Gershengorn M. C., Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997; 385: 347–350
   PubMed Web of Science ®Google Scholar
• Richardson R. M., Pridgen B. C., Haribabu B., Ali H., Snyderman R. Differential cross-regulation of the human chemokine receptors CXCRI and CXCR2. Evidence for time-dependent signal generation. Journal of Biological Chemistry 1998; 273: 23830–23836
   PubMed Web of Science ®Google Scholar
• Ali H., Richardson M. R., Haribabu B., Snyderman R. Chemoattractant receptor cross-desensitization. Journal of Biological Chemistry 1999; 274: 6027–6030
   PubMed Web of Science ®Google Scholar
• Khandaker M. H., Mitchell G., Xu L., Andrews J. D., Singh R., Hung H., Madrenas J., Ferguson S. S., Feldman R. D., Kelvin D. J. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCRI and CXCR2 chemokine receptor expression. Blood 1999; 93: 2173–2185
   PubMed Web of Science ®Google Scholar
• Fibbe W. E., Pruijt J. F., Velders G. A., Opdenakker G., van Kooyk Y., Figdor C. G., Willemze R. Biology of IL-8-induced stem cell mobilization. Annuls of New York Academy of Sciences 1999; 872: 71–82
   PubMed Web of Science ®Google Scholar
• Norgauer J., Metzner B., Schraufstatter I. Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. Journal of Immunology 1996; 156: 1132–137
   PubMed Web of Science ®Google Scholar
• Burger M., Burger J. A., Hoch R. C., Zenaida O., Takamori H., Schraufstatter I. U. Point mutation causing constitutive signalling of CXCR-2 leads to transforming activity similar to Kaposi's sarcoma Herpesvirus-G protein-coupled receptor. Journal of Immunology 1999; 163: 2017–2022
   PubMed Web of Science ®Google Scholar
• di Celle P. F., Mariani S., Riera L., Stacchini A., Reato G., Foa R. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 1996; 87: 4382–4389
   PubMed Web of Science ®Google Scholar
• Han Z. C., Lu M., Li J., Defard M., Boval B., Schlegel N., Caen J. P. Platelet factor 4 and other CXC chem-okines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents. Blood 1997; 89: 2328–2335
   PubMed Web of Science ®Google Scholar
• Lippert E., Jacques Y., Hermouet S. Positive regulation of human T-cell activation by Gi2 proteins and interleukin 1999; 8, submitted
   Google Scholar
• Gewirtz A. M., Zhang J., Ratajczak J., Ratajczak M., Park K. S., Li C., Yan Z., Poncz M. Chemokine regulation of human megakaryocytopoiesis. Blood. 1995; 86: 2559–2567
   PubMed Web of Science ®Google Scholar
• Lu L., Xiao M., Grigsby S., Wang W. X., Wu B., Shen R. N., Broxmeyer H. E. Comparative effects of suppressive cytokines on isolated single CD34+ stedprogenitor cells from human bone marrow and umbilical cord blood plated with or without serum. Experimental Hematology 1993; 21: 1442–1446
   PubMed Web of Science ®Google Scholar
• Cacalano G., Lee J., Kikly K., Ryan A. M., Pitts-Meek S., Hultgren B., Wood W. I., Moore M. W. Neu-trophil and B cell Expansion in mice that lack the murine IL-8 receptor homolog. Science. 1994; 265: 682–684
   PubMed Web of Science ®Google Scholar
• Broxmeyer H. E., Cooper S., Cacalano G., Hague N. L., Bailish E., Moore M. W. Involvement of inter-leukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue. Journal of Experimental Medicine 1996; 184: 1825–1832
   PubMed Web of Science ®Google Scholar
• Damaj B. B., McColl S. R., Mahana W., Crouch M. F., Naccache P. H. Physical association of Gi2a with interleukin-8 receptors. Journal of Biological Chemistry 1996; 271: 12783–12789
   PubMed Web of Science ®Google Scholar
• Xie W., Jiang H., Wu D. Two amino acids in the second inner loop of the interleukin-8 receptor are essential for Galpha16 coupling. Journal of Biological Chemistry 1997; 272: 24948–24951
   PubMed Web of Science ®Google Scholar
• Arai H., Charo I. F. Differential regulation of G-protein-mediated signaling by chemokine receptors. Journal of Biological Chemistry 1996; 271: 21814–21819
   PubMed Web of Science ®Google Scholar
• Van Lint J., Van Damme J., Billiau A., Merlevede W., Vandenheede J. R. Interleukin-8 activates microtu-bule-associated protein 2 kinase (ERK1) in human neutrophils. Molecular and Cellular Biochemistry 1993; 127–128, 171–177
   Google Scholar
• Bacon K. B., Quinn D. G., Aubry J. P., Camp R. D. Interleukin-8-stimulated polyphosphoinositide hydrolysis in human peripheral blood lymphocytes. Blood. 1993; 81: 430–436
   PubMed Web of Science ®Google Scholar
• L'Heureux G. P., Bourgoin S., Jean N., McColl S. R., Naccache P. H. Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin- 8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity. Blood 1995; 85: 522–531
   PubMed Web of Science ®Google Scholar
• Knall C., Worthen G. S., Jonhson G. L. Inter-leukin-8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-acti-vated protein kinases. Proceedings of the National Academy of Sciences 1997; 94: 3052–3057
   PubMed Web of Science ®Google Scholar
• Hermouet S., Merendino J. J., Jr, Gutkind J. S., Spiegel A. M. Activating and inactivating mutations of the a subunit of Gi2 protein have opposite effects on proliferation of NIH 3T3 cells. Proceedings of the National Academy of Sciences USA 1991; 88: 10455–10459
   PubMed Web of Science ®Google Scholar
• Dhanasekaran N., Tsim S. -T., Dermott J. M., Onesime D. Regulation of cell proliferation by G proteins. Oncogene 1998; 17: 1383–1394, Review Issue 1
   PubMed Web of Science ®Google Scholar
• Come I., Baumann H., Hermouet S. Regulation by Gi2 proteins of v-fms-induced proliferation and transformation via Src-kinase and STAT3. Oncogene 1999; 18: 6335–6342
   PubMed Web of Science ®Google Scholar
• Corre I., Hermouet S. Regulation of CSF-I-induced proliferation by heterotrimeric Gi2 proteins. Blood 1995; 86: 1776–1783
   PubMed Web of Science ®Google Scholar
• Corey S. J., Anderson S. M. Src-related protein tyrosine kinases in hematopoiesis. Blood 1999; 93: 1–14
   PubMed Web of Science ®Google Scholar
• Courtneidge S. A., Dhand R., Pilat D., Twamley G. M., Waterfield M. I., Roussel M. F. Activation of Src family kinases by Colony Stimulating Factor 1, and their association with its receptor. EMBO Journal 1993; 1: 943–950
   Google Scholar
• Tilbrook P. A., Ingley E., Williams J. H., Hibbs M. L., Klinken S. P. Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E cells. EMBO Journal 1997; 16: 1610–1619
   PubMed Web of Science ®Google Scholar
• Chaturvedi P., Reddy Ramana M.V., Reddy Premkumar E. Src-kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation. Oncogene 1998; 16: 1749–1758
   PubMed Web of Science ®Google Scholar
• Fukada T., Hibi M., Yamanaka Y., Takahashi-Tezuka M., Fujitani Y., Yamaguchi T., Nakajima K., Hirano T. Two signals are necessary for cell proliferation induced by a cytokine receptor, gp130: Involvement of STAT3 in anti-apoptosis. Immunity 1996; 5: 449–460
   PubMed Web of Science ®Google Scholar
• Koyasu S., Miyajima A., Arai K., Okajima F., Ui M., Yahara I. Growth regulation of multi-factor-dependent myeloid cell lines: IL- 4, TGF-P and pertussis toxin modulate IL-3– or GM-CSF-induced growth by controlling cell cycle length. Cellular Structure and Function 1989; 14: 459–471
   PubMed Web of Science ®Google Scholar
• Miller B. A., Foster K., Robishaw J. D., Whitfield C. F., Bell L., Cheung J. Y. Role of pertussis toxin-sensitive guanosine triphosphate-binding proteins in the response of erythroblasts to erythropoietin. Blood 1991; 77: 486–492
   PubMed Web of Science ®Google Scholar
• Amatruda T. T., II, Steele I. D. A., Slepak V. Z., Simon M. I. Gα 16, a G protein α subunit specifically expressed in hematopoietic cells. Proceedings of the National Academy of Sciences USA 1991; 88: 5587–5591
   PubMed Web of Science ®Google Scholar
• Tenailleau S., Corre I., Hermouet S. Specific expression of heterotrimeric GTP-binding proteins G12 and G16 during human myeloid differentiation. Experimental Hematology 1997; 25: 927–934
   PubMed Web of Science ®Google Scholar
• Mapara M. Y., Bommert K., Bargou R. C., Leng C., Beck C., Ludwig W. D., Gierschik P., Dörken B. G protein subunit Gα16 expression is restricted to progenitor B cells during human B-cell differentiation. Blood 1995; 85: 1836–1842
   PubMed Web of Science ®Google Scholar
• Lippert E., Baltensperger K., Jacques Y., Hermouet S. Gα16 protein expression is up- and down-regulated following T-cell activation: Disruption of this regulation impairs activation-induced cell responses. FEBS Letters 1997; 411: 292–296
   Web of Science ®Google Scholar
• Qian N. -X., Russell M., Buhl A. M., Johnson G. L. Expression of GTPase-deficient Gα16 inhibits Swiss 3T3 cell growth. Journal of Biological Chemistry. 1994; 269: 17417–17423
   PubMed Web of Science ®Google Scholar
• Mayani H., Little M. T., Dragowska W., Thornbury G., Lansdorp P. M. Differential effects of the hematopoietic inhibitors MIP-la, TGF-β, and TNF-α on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver. Experimental Hematology 1995; 23: 422–427
   PubMed Web of Science ®Google Scholar
• Van Ranst P. C. F., Snoeck H. -W., Lardon F., Lenjou M., Nijs G., Weekx S. F. A., Rodrigus I., Berneman Z. N., Van Bockstaele D. R. TGF-β and MIP-lα exert their main inhibitory activity on very primitive CD34++CD38-cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors. Experimental Hematology 1996; 24: 1509–1515
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. M., Conti A. Modulation of hematopoiesis via alpha-1 adrenergic receptors on bone marrow cells. Experimental Hematology 1994; 22: 314–320
   Google Scholar
• Marino F., Cosentino M., Bombelli R., Ferrari M., Lecchini S., Frigo G. Endogenous catecholamine synthesis, metabolism, storage, and uptake in human peripheral blood mononuclear cells. Experimental Hematology 1999; 27: 489–495
   PubMed Web of Science ®Google Scholar
• Taub D. D., Ortaldo J. R., Turcovski-Corrales S. M., Key M. L., Longo D. L., Murphy W. J. β chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. Journal of Leukocyte Biology. 1996; 59: 81–89
   PubMed Web of Science ®Google Scholar
• de Wynter E. A., Durig J., Cross M. A., Heyworth C. M., Testa N. G. Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-lalpha and the expression of MIP-lalpha receptors on these immature cells. Stem Cells 1998; 16: 349–356
   PubMed Web of Science ®Google Scholar
• Broxmeyer H. E., Cooper S., Hangoc G., Gao J. L., Murphy P. M. Dominant myelopoietic effector functions mediated by chemokine receptor CCRl. Journal of Experimental Medicine 1999; 189: 1987–1992
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. Is hematopoiesis under the influence of neural and neuroendocrine mechanisms?. Histology and Histopathology 1998; 13: 271–274
   PubMed Web of Science ®Google Scholar
• Valk P. J., Delwel R. The peripheral cannabinoid receptor, Cb 2, in retrovirally-induced leukemic transformation and normal hematopoiesis. Leukemia and Lymphoma 1998; 32: 29–43
   PubMed Web of Science ®Google Scholar
• Tian M., Broxmeyer H. E., Fan Y., Lai Z., Zhang S., Aronica S., Cooper S., Bigsby R. M., Steinmetz R., Engle S. J., Mestek A., Pollock J. D., Lehman M. N., Jansen H. T., Ying M., Stambrook P. J., Tischfield J. A., Yu L. Altered hematopoiesis, behavior, and sexual function in opiold receptor-deficient mice. Journal Experimental Medecine 1997; 185: 1517–1522
   PubMed Web of Science ®Google Scholar
• Mori N., Mukaida N., Ballard D. W., Matsushima K., Yamamoto N. Human T-cell leukemia virus type-1 Tax transactivates human interleukin-8 gene through acting concurrently on AP-1 and nuclear factor-kappaB-like sites. Cancer Research 1998; 58: 3993–4000
   PubMed Web of Science ®Google Scholar
• Doranz B. J., Rucker J., Yanjie Y., Smyth R. J., Samson M., Peiper S. C., Parmentier M., Collman R. G., Doms R. W. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR- 5, CKR-3 and CKR-2b as fusion cofactors. Cell 1996; 85: 1149–1158
   PubMed Web of Science ®Google Scholar
• Khabar K. S., Al-Zoghaibi F., Al-Adhal M. N., Murayama T., Dhalla M., Mukaida N., Taha M., Al-Sedairy S. T., Siddiqui Y., Kessie G., Matsushima K. The alpha chemokine, interleukin- 8, inhibits the antiviral action of interferon alpha. Journal of Experimental Medicine 1997; 186: 1077–1085
   PubMed Web of Science ®Google Scholar
• Gill P. S., Harrington W., Jr, Kaplan M. H., Ribeiro R. C., Bennett J. M., Liebmann H. A., Bernstein-Singer M., Espina B. M., Cabral L., Allen S., et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alpha and zidovudine. New England Journal of Medicine 1995; 332: 1744–1748
   PubMed Web of Science ®Google Scholar
• Singhal S., Powles R., Trelaven J., Mehta J. Sensitivity of secondary acute myeloid leukemia relapsing after allogenic bone marrow transplantation to immunotherapy with interferon-alpha 2b. Bone Marrow Transplantation 1997; 19: 1151–1153
   PubMed Web of Science ®Google Scholar
• Nagafuji K., Harada N., Eto T., Hayashi S., Kamimura T., Gondo H., Niho Y. Interferon-alpha treatment of acute lymphoblastic leukemia relapse after unrelated bone marrow transplantation. International Journal of Hematology 1998; 61: 63–68
   Google Scholar
• Geras-Raaka E., Arvanitakis L., Bais C., Cesarman E., Mesri E. A., Gershengom M. C. Inhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein-kinases in mammalian cells in culture. Journal of Experimental Medicine 1998; 18: 801–806
   Web of Science ®Google Scholar
• Geras-Raaka E., Varma A., Ho H., Clark-Lewis I., Gershengom M. C. Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Journal of Experimental Medicine 1998; 18: 801–806
   Web of Science ®Google Scholar